Ignite Creation Date:
2024-05-06 @ 2:33 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02063789
Status:
COMPLETED
Last Update Posted:
2016-05-25
First Post:
2014-02-13
Brief Title:
An Open Phase 3 Study of IV-Globulin SN Inj10 to Treat Immune Thrombocytopenia
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp